
Kathleen Kahler Fonda
Examiner (ID: 16259)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1621, 1211, 1622, 1803 |
| Total Applications | 685 |
| Issued Applications | 444 |
| Pending Applications | 93 |
| Abandoned Applications | 148 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19931732
[patent_doc_number] => 12304929
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-20
[patent_title] => Recombinant RSV live vaccine strain and the preparing method thereof
[patent_app_type] => utility
[patent_app_number] => 17/717504
[patent_app_country] => US
[patent_app_date] => 2022-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 6220
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17717504
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/717504 | Recombinant RSV live vaccine strain and the preparing method thereof | Apr 10, 2022 | Issued |
Array
(
[id] => 19201471
[patent_doc_number] => 20240173370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => CONTROLLED RELEASE OF BACTERIOPHAGE TO TREAT IMPLANT INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/552406
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4259
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552406
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/552406 | CONTROLLED RELEASE OF BACTERIOPHAGE TO TREAT IMPLANT INFECTIONS | Mar 24, 2022 | Pending |
Array
(
[id] => 17990175
[patent_doc_number] => 20220356212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => MODIFIED SPIKE PROTEIN AND METHOD OF TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/705090
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17705090
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/705090 | MODIFIED SPIKE PROTEIN AND METHOD OF TREATMENT | Mar 24, 2022 | Abandoned |
Array
(
[id] => 19158019
[patent_doc_number] => 20240150726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => Method for Producing Recombinant AAV9 Virion
[patent_app_type] => utility
[patent_app_number] => 18/280543
[patent_app_country] => US
[patent_app_date] => 2022-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14786
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18280543
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/280543 | Method for Producing Recombinant AAV9 Virion | Mar 7, 2022 | Pending |
Array
(
[id] => 17895450
[patent_doc_number] => 20220305112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => NOVEL METHODS AND USES
[patent_app_type] => utility
[patent_app_number] => 17/680433
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17680433
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/680433 | NOVEL METHODS AND USES | Feb 24, 2022 | Abandoned |
Array
(
[id] => 19051265
[patent_doc_number] => 20240093234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => CHIMERIC ADENOVIRAL VECTORS
[patent_app_type] => utility
[patent_app_number] => 18/263462
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31497
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18263462
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/263462 | CHIMERIC ADENOVIRAL VECTORS | Jan 30, 2022 | Pending |
Array
(
[id] => 19909289
[patent_doc_number] => 12285476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-29
[patent_title] => Amino acid sequence derived from S protein of SARS-CoV2 for generating an anti-SARS-CoV-2 antibody
[patent_app_type] => utility
[patent_app_number] => 17/578049
[patent_app_country] => US
[patent_app_date] => 2022-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 0
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17578049
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/578049 | Amino acid sequence derived from S protein of SARS-CoV2 for generating an anti-SARS-CoV-2 antibody | Jan 17, 2022 | Issued |
Array
(
[id] => 19020581
[patent_doc_number] => 20240076752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => METHODS FOR DETECTION OF NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 18/260447
[patent_app_country] => US
[patent_app_date] => 2022-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18260447
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/260447 | METHODS FOR DETECTION OF NUCLEIC ACIDS | Jan 4, 2022 | Pending |
Array
(
[id] => 18818795
[patent_doc_number] => 20230393135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => Cell-Free Method For The Quantitative Measurement Of Virus Neutralizing Antibodies
[patent_app_type] => utility
[patent_app_number] => 18/032920
[patent_app_country] => US
[patent_app_date] => 2021-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032920
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/032920 | Cell-Free Method For The Quantitative Measurement Of Virus Neutralizing Antibodies | Nov 1, 2021 | Pending |
Array
(
[id] => 17564411
[patent_doc_number] => 20220128560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => HIGH THROUGHOUT IMMUNOASSAYS AND METHODS FOR THE DETECTION OF SARS-COV-2 ANTIGENS
[patent_app_type] => utility
[patent_app_number] => 17/513538
[patent_app_country] => US
[patent_app_date] => 2021-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4296
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17513538
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/513538 | HIGH THROUGHOUT IMMUNOASSAYS AND METHODS FOR THE DETECTION OF SARS-COV-2 ANTIGENS | Oct 27, 2021 | Abandoned |
Array
(
[id] => 19954436
[patent_doc_number] => 12324833
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-10
[patent_title] => Recombinant severe respiratory syndrome coronavirus 2 Rbd trimer protein vaccine capable of generating broad-spectrum cross neutralization activity, and preparation method and use thereof
[patent_app_type] => utility
[patent_app_number] => 18/277087
[patent_app_country] => US
[patent_app_date] => 2021-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 4573
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277087
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/277087 | Recombinant severe respiratory syndrome coronavirus 2 Rbd trimer protein vaccine capable of generating broad-spectrum cross neutralization activity, and preparation method and use thereof | Sep 23, 2021 | Issued |
Array
(
[id] => 18256891
[patent_doc_number] => 20230083931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => CORONAVIRUS VACCINES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/481781
[patent_app_country] => US
[patent_app_date] => 2021-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 170288
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -66
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17481781
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/481781 | CORONAVIRUS VACCINES AND METHODS OF USE | Sep 21, 2021 | Pending |
Array
(
[id] => 17441901
[patent_doc_number] => 20220062406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => IMMUNE MEMORY ENHANCED PREPARATIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/460026
[patent_app_country] => US
[patent_app_date] => 2021-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12819
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17460026
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/460026 | IMMUNE MEMORY ENHANCED PREPARATIONS AND USES THEREOF | Aug 26, 2021 | Abandoned |
Array
(
[id] => 19763337
[patent_doc_number] => 12221616
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-11
[patent_title] => Adeno-associated virus variant capsids and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/400041
[patent_app_country] => US
[patent_app_date] => 2021-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 30
[patent_no_of_words] => 36329
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17400041
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/400041 | Adeno-associated virus variant capsids and methods of use thereof | Aug 10, 2021 | Issued |
Array
(
[id] => 17400027
[patent_doc_number] => 20220042117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => COMPOSITIONS AND METHODS FOR THE SIMULTANEOUS DETECTION OF INFLUENZA A, INFLUENZA B, AND SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)
[patent_app_type] => utility
[patent_app_number] => 17/393742
[patent_app_country] => US
[patent_app_date] => 2021-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17393742
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/393742 | COMPOSITIONS AND METHODS FOR THE SIMULTANEOUS DETECTION OF INFLUENZA A, INFLUENZA B, AND SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2) | Aug 3, 2021 | Pending |
Array
(
[id] => 17412792
[patent_doc_number] => 20220047696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => ANTI-CORONAVIRUS VACCINES
[patent_app_type] => utility
[patent_app_number] => 17/389724
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10537
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17389724
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/389724 | Anti-coronavirus vaccines | Jul 29, 2021 | Issued |
Array
(
[id] => 18656237
[patent_doc_number] => 20230302123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => REPLICATION-DEFICIENT ADENOVIRUS
[patent_app_type] => utility
[patent_app_number] => 18/007364
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9862
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007364
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007364 | REPLICATION-DEFICIENT ADENOVIRUS | Jul 29, 2021 | Pending |
Array
(
[id] => 18583195
[patent_doc_number] => 20230265455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => IMPROVED AAV-MEDIATED X-LINKED RETINOSCHISIS THERAPIES
[patent_app_type] => utility
[patent_app_number] => 18/017726
[patent_app_country] => US
[patent_app_date] => 2021-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32505
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -52
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017726
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017726 | IMPROVED AAV-MEDIATED X-LINKED RETINOSCHISIS THERAPIES | Jul 27, 2021 | Pending |
Array
(
[id] => 19949449
[patent_doc_number] => 12320809
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-03
[patent_title] => Method for measuring viral antigen in sample, antibody set, and reagent kit
[patent_app_type] => utility
[patent_app_number] => 17/387409
[patent_app_country] => US
[patent_app_date] => 2021-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 5810
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 246
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17387409
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/387409 | Method for measuring viral antigen in sample, antibody set, and reagent kit | Jul 27, 2021 | Issued |
Array
(
[id] => 18649428
[patent_doc_number] => 20230295238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => INSULIN RECEPTOR-MEDIATED ENHANCEMENT OF GENE TRANSFER
[patent_app_type] => utility
[patent_app_number] => 18/017175
[patent_app_country] => US
[patent_app_date] => 2021-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017175
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017175 | INSULIN RECEPTOR-MEDIATED ENHANCEMENT OF GENE TRANSFER | Jul 18, 2021 | Pending |